Patsy
A
thread 1/2
Eric Topol:
This drug class [GLP-1] is exceeding all expectations, well beyond weight loss, with new clinical trial data this week for heart disease and #Parkinsons
A rundown and where we're headed in the new https://erictopol.substack... Ground Truths
09:05 AM - Apr 07, 2024
Avatar Avatar Avatar
0
0
4
Patsy
A
thread 2/2
Eric Topol:
Note the asterisk at the bottom of the Figure—patients without diabetes
Patients with diabetes weight loss was 40% less at the same dose of semaglutide in a new trial. We don't know why.
The longstanding mystery also accounts, in part, for the marked delay of testing GLP-1 drugs…
09:09 AM - Apr 07, 2024
0
2

 

{{ notificationModalContent }} {{ promptModalMessage }}